Sector
PharmaceuticalsOpen
₹29.33Prev. Close
₹29.33Turnover(Lac.)
₹0.29Day's High
₹29.33Day's Low
₹29.3352 Week's High
₹29.3352 Week's Low
₹18.94Book Value
₹13.04Face Value
₹10Mkt Cap (₹ Cr.)
73.18P/E
0EPS
0.03Divi. Yield
020 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
2 Sep 2024
12:00 AM
AGM
Announcement Date: 02 Sep, 2024
12 Apr 2025
12:00 AM
EGM
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 8.1 | 8.1 | 8.1 | 8.1 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -0.75 | -0.9 | -0.86 | 0.7 |
Net Worth | 7.35 | 7.2 | 7.24 | 8.8 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2017 | Mar-2016 | Mar-2015 | Mar-2014 |
|---|---|---|---|---|
Revenue | 3.5 | 0.92 | 1.45 | 5.74 |
yoy growth (%) | 277.33 | -36.13 | -74.63 | -3.58 |
Raw materials | -2.84 | 0 | -0.32 | -4.24 |
As % of sales | 81.2 | 0 | 22.17 | 73.84 |
Employee costs | -0.21 | -0.23 | -0.06 | -0.33 |
| Y/e 31 Mar( In .Cr) | Mar-2017 | Mar-2016 | Mar-2015 | Mar-2014 |
|---|---|---|---|---|
Profit before tax | 0.2 | 0.13 | 0.08 | 0.6 |
Depreciation | -0.12 | -0.33 | -0.39 | -0.28 |
Tax paid | -0.05 | -0.03 | -0.06 | -0.19 |
Working capital | 1.37 | -1.5 | -0.84 | 0.27 |
Other operating items |
| Y/e 31 Mar | Mar-2017 | Mar-2016 | Mar-2015 | Mar-2014 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 277.33 | -36.13 | -74.63 | -3.58 |
Op profit growth | -53.77 | -18.59 | -45.17 | 8.52 |
EBIT growth | 50.64 | 47.78 | -85.1 | 11.11 |
Net profit growth | 53.57 | 427.68 | -95.52 | 10.19 |
| Particulars (Rupees in Crores.) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|---|
Gross Sales | 8.61 | 9.24 | 10.24 | 10.46 | 10.5 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 8.61 | 9.24 | 10.24 | 10.46 | 10.5 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 0.64 | 0.34 | 0.6 | 0.38 | 0.21 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.35 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493.2 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,483.15 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.4 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,167.95 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Independent Director
Monam Kapoor
Independent Director
Janardhan Das Kabra
Whole-time Director
Venkateshwarlu Pulluru
Company Sec. & Compli. Officer
Nishita Kalantri
Non Executive Director
Jivamohan Divakar Valluri
Non Executive Director
Lakshman Samala
4-4-231/1/2/ABC Inderbagh,
Sultan Bazar,
Telangana - 500095
Tel: 91-40-24757370
Website: http://www.trimurthidrugs.com
Email: info@trimurthidrugs.com
12-10-167,
Bharath Nagar,
Hyderbad - 500018
Tel: 91-040-23818475/76/2
Website: www.vccilindia.com
Email: info@vccilindia.com
Summary
Trimurthi Limited was formerly incorporated on December 13, 1994 with the name Trimurthi Securities Ltd. The name of the Company thereafter got changed from Trimurthi Securities Ltd to Trimurthi Drugs...
Read More
Reports by Trimurthi Ltd
What is the Novelix Pharmaceuticals Ltd share price today?
What is the Market Cap of Novelix Pharmaceuticals Ltd?
What is the PE and PB ratio of Novelix Pharmaceuticals Ltd?
What is the 52 Week High and Low of Novelix Pharmaceuticals Ltd?
What is the CAGR of Novelix Pharmaceuticals Ltd?
What is the shareholding pattern of Novelix Pharmaceuticals Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.